Skip to Content

'
Miguel A. Rodriguez-Bigas, MD, FACS, FASCRS

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1982 University of Puerto Rico School of Medicine, San Juan, PR, MD, Medical Degree
1978 George Washington University, Washington, DC, BS, Chemistry

Postgraduate Training

1989-1990 Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1988-1989 Head & Neck Surgery Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1987-1988 Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1983-1987 General Surgery Resident, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR
1982-1983 General Surgery Internship, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR

Board Certifications

2006 American Board of Surgery
1997 American Board of Surgery
1988 American Board of Surgery
1983 National Board of Medical Examiners,

Experience/Service

Academic Appointments

Associate Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1998-2001
Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1991-1998
Clinical Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1990-1991

Administrative Appointments/Responsibilities

Chief, Division of Colorectal Surgery, Department of Surgery, Roswell Park Cancer Institute, Buffalo, NY, 1/2000-6/2001
Adjunct Faculty, Physician Assistant Program, DYouville College, Buffalo, NY, 5/1994-6/2001
Director, Hereditary Nonpolyposis Colorectal Cancer Registry, Roswell Park Cancer Institute, Buffalo, NY, 1/1993-6/2001
Director, Familial Polyposis Registry, Roswell Park Cancer Institute, Buffalo, NY, 1/1990-6/2001

Other Appointments/Responsibilities

Associate Member, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, 9/2007-present

Institutional Committee Activities

Member, The University of Texas M. D. Anderson Cancer Center, Faculty Senate, 1/2005-2008

Honors and Awards

2011 Best Doctors in America
2010 Best Doctors in America
2009 Best Doctors in America
2008 America's Top Oncologists, Guide to America's Top Oncologists
2008 Best Doctors in America
2007 Best Doctors in America
2006 Best Doctors in America
2005 Best Doctors in America
2005 Outstanding Teacher Award, University of Texas M. D. Anderson Cancer Center
1999 Golden Apple Teaching Award, Best Teacher of the Year, Roswell Park Cancer Institute
1999 Outstanding Patient Care Award, Roswell Park Cancer Institute
1996 Ambassador, The Greater Buffalo Convention and Visitors Bureau
1996 Outstanding Young Men of America
1995 "40 Under Forty" Honor Roll, Buffalo's Business First, Western New York's Business Newspaper
1992 Citation's Who's Who Among Rising Young Americans in American Society and Business
1989-1990 Clinical Oncology Fellowship, The American Cancer Society
1988 Third Prize; Annual Residents and Fellows Essay Contest, Western New York Chapter of The American College of Surgeons

Professional Memberships

American Association for Cancer Research
Member, 1993-present
American Cancer Society
Member, 2003-present
Colorectal Cancer Advisory Committee, 2003-2009
American College of Surgeons
Fellow, 1993-present
American College of Surgeons Oncology Group
Audit Committee, 2002-2011
Colon and Rectal Organ Site Committee, 2000-2011
Member, 2000-2011
American College of Surgeons, Commission on Cancer
Executive Committee, 2007-2009
American Society for Gastrointestinal Endoscopy
Member, 1990-present
American Society of Clinical Oncology
Member, 1993-present
American Society of Colon and Rectal Surgeons
Fellow, 2001-present
Association for Academic Surgery
Member, 1989-present
Collaborative Group of the Americas on Inherited Colorectal Cancer
Executive Council Member at Large, 2001-2004
Member, 1998-present
Harris County Medical Society
Member, 2001-present
International Society for Hereditary Gastrointestinal Tumors (INSIGHT)
Council Member, 2011-2013
Co-Chair elect, 2009-2011
Council Member, 2003-2009
Society of American Gastrointestinal Endoscopic Surgeons
Member, 1991-present
Society of Surgical Oncology
Member, 1992-present
Society of University Surgeons
Member, 1998-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Carmack CL, Basen-Engquist K, Yuan Y, Greisinger A, Rodriguez-Bigas M, Wolff RA, Barker T, Baum G, Pennebaker JW. Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: Results of the healthy expressions study. Cancer 117(21):4993-5002, 11/1/2011. e-Pub 4/8/2011. PMID: 21480203.
2. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-22, 8/15/2011. e-Pub 2/15/2011. PMCID: PMC3266661.
3. You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal Cancer. Ann Surg Oncol. e-Pub 12/4/2010. PMID: 21132391.
4. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 17(11):2863-9, 11/2010. e-Pub 6/15/2010. PMID: 20552409.
5. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am 19(4):847-59, 10/2010. PMID: 20883958.
6. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210(6):934-41, 6/2010. PMID: 20510802.
7. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated Accelerated Radiotherapy for Rectal Cancer in Patients with Prior Pelvic Irradiation. Int J Radiat Oncol Biol Phys 77(1):60-5, 5/1/2010. e-Pub 8/19/2009. PMID: 19695792.
8. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 76(3):824-30, 3/1/2010. e-Pub 5/21/2009. PMID: 19464823.
9. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-4, 2/2010. PMID: 19864936.
10. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 17(2):441-7, 2/2010. e-Pub 10/22/2009. PMID: 19847569.
11. Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer 9(2):99-107, 2010. e-Pub 9/2009. PMID: 19731080.
12. De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer 9(2):155-166, 2010. e-Pub 12/2009. PMID: 20012372.

Abstracts
1. Bowles TL, Hu C, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Cancers of the colon and rectum. Proc ASCO GI, 2010.
2. Chang G, Maru D, Afarwal A, Schlette E, Wolff R, Rodriguez-Bigas MA, You YN, Feig B, Kopetz S, Skibber J, Eng C. Histopathologic responses in primary tumors of patients with metastatic colorectal carcinoma after neoadjuvant systemic chemotherapy alone. ESMO Conference: 12th World Congress on Gastrointestinal Cancer, 2010.
3. You YN, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer. Proc ASCO, 2010.
4. Tsa CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BF, Eng C, Delclos M, Krishnan S, Das P. Number of lymph nodes retrieved and prognosis among pathologically node-negative patients after preoperative chemoradiation therapy for rectal cancer. Proc ASCO, 2010.
5. You YN, Halim H, Chang GJ, Rodriguez-Bigas MA. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer. Proc SSO, 2010.
6. You YN, Saraiya D, Vu TM, Veerapong J, Lynch PM, Rodriguez-Bigas MA. Rectal cancer in patients with hereditary nonpolyposis colorectal cancer: surgical management and survival outcomes. 14th Annual Meeting of the Collaborative Group of the Americas on Colorectal Cancer, 2010.
7. Tanaka M, Bedrosian I, Chang GJ, You NY, Li D, Rodriguez-Bigas MA, Skibber JM, Abbruzzese JL, Eng C. Single nucleotide polymorphisms (SNPs) of hypoxia-related genes correlate with pathological complete response following neoadjuvant chemotherapy for locally advanced rectal cancer. Proc ASCO, 2010.
8. Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas MA. Structured reporting for MRI staging of rectal cancer. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2010.
9. Saraiya D, You YN, Askew RL, Vu TM, Lynch PM, Rodriguez-Bigas MA. The importance of tumor studies in the initial evaluation for Lynch Syndrome: a coparison of MMR postive and negative patients. 14th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer, 2010.
10. Eng C, Sethi S, Chang G, Rodriguez-Bigas M, Skibber J, Shen J, Zhu J, Ohinata A, Hamilton S, Li D. Proteomic analysis of potential tumor markers in AJCC stage II and III colon cancer. Proc ASCO, 2009.

Book Chapters
1. Bhadkamkar N, Crane CH, Rodriguez-Bigas MA, Kopetz S, Eng C. Colorectal Cancer. In: The MD Anderson Manual of Medical Oncology, 2nd. Ed(s) Kantarjian HM, Wolff RA, Koller CA. McGraw-Hill: New York, 549-588, 2011. ISBN: 978-0-07-170106-8.
2. Alberts AR, Citrin D, Rodriguez-Bigas MA, Das P. Colon, Rectal, and anal cancers. In: Cancer Management: A Multidisciplinary Approach. 12th. Ed(s) Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ. CMP Media, 2010.
3. Rodriguez-Bigas MA. Genotype phenotype correlation in familial adenomatous polyposis. In: Hereditary Colorectal Cancer. Ed(s) Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Springer: New York, 197-202, 2010.
4. Rodriguez-Bigas, MA. Polipose associada ao MYH (PAM). In: Polipose Adenomatosa Familiar. Yendis: Sao Paulo, Brazil, 2010. ISBN: 978-85-7728-176-3.
5. Cutait R, Rodriguez-Bigas MA. Surgical management in Lynch Syndrome. In: Hereditary Colorectal Cancer. Ed(s) Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Springer: New York, 301-310, 2010.

Books (edited and written)
1. Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Hereditary Colorectal Cancer. In: M. D. Anderson Solid Tumor Oncology Series. Springer: New York, 2010. ISBN: 978-1-4419-6602-5.

Last updated: 3/4/2013